Majed Al Jeraisy

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

Yaseen M. Arabi, Adel Alothman, Hanan H. Balkhy et al. · Trials · 2018 · 261 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial

Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri et al. · Trials · 2020 · 132 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial

Mohammad Bosaeed, Ahmad M. Alharbi, Ebrahim Mahmoud et al. · Clinical Microbiology and Infection · 2022 · 103 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome

Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri et al. · New England Journal of Medicine · 2020 · 80 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial

Faizah Alotaibi, Naif Khalaf Alharbi, Lindsey B. Rosen et al. · Influenza and Other Respiratory Viruses · 2023 · 47 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14